Monograph Details
|
|
Immune System
> Immunization
|
|
HIBTITER |
| Manufacturer |
|
Wyeth Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Hib (HbOC). |
| Generic Name |
|
Haemophilus b conjugate vaccine (diphtheria CRM197 conjugate) 10micrograms capsular oligosaccharides, 25micrograms diphtheria CRM197 protein; per 0.5mL dose; IM inj; multidose vials contain thimerosal. |
| Indications |
|
Immunization of children against H. influenza type b. |
| Children |
|
<2 months: not recommended. At 2, 4, and 6 months: 0.5mL IM. Previously unvaccinated children, 7–11 months: 2 doses of 0.5mL IM 2 months apart. 12–14 months: 0.5mL IM once. All children vaccinated before 15 months of age should receive booster at 15 months (but not less than 2 months after previous shot). 15–60 months: 0.5mL IM once. |
| Precautions |
|
Immunodeficiency (HIV infection: see literature). Delay administration in febrile or active infection. Have epinephrine inj (1:1000) available. Protection begins several days after vaccination. Not a substitute for routine diphtheria vaccination. Pregnancy (Cat.C): not recommended. |
| Adverse Reactions |
|
Local reactions, fever. |
| How Supplied |
|
Single-dose vial—5 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
